AMETEK (AME) awards director Dean Seavers 950 restricted shares

Rhea-AI Filing Summary

AMETEK Inc. director Dean Seavers reported an equity award of company stock. On this Form 4, he acquired 950 shares of AMETEK common stock as a grant or award valued at $212.77 per share. The shares constitute restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan.

Following this award, Seavers directly holds 5,600 shares of AMETEK common stock. This transaction reflects compensation in stock rather than an open-market purchase.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Seavers Dean

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	950	$212.77	$202K

Holdings After Transaction: Common Stock — 5,600 shares (Direct)

Footnotes (1)

1. [object Object]

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Seavers Dean

(Last) (First) (Middle)

AMETEK, INC.

1100 CASSATT RD

(Street)

BERWYN PENNSYLVANIA 19312

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AMETEK INC/ [ AME ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/18/2026		A(1)		950	A	$212.77	5,600	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Constitutes restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan.

Remarks:

	/s/ Lynn Carino, attorney-in-fact for Mr. Seavers	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did AMETEK (AME) director Dean Seavers report on this Form 4?

Dean Seavers reported receiving an award of 950 shares of AMETEK common stock. The shares were granted as restricted stock under the company’s 2020 Omnibus Incentive Compensation Plan and are reported as an acquisition of non-derivative common stock.

Was Dean Seavers’ AMETEK Form 4 transaction an open-market stock purchase?

No, the Form 4 shows a grant or award acquisition, not an open-market purchase. The 950 shares of common stock were issued as restricted stock under AMETEK’s 2020 Omnibus Incentive Compensation Plan, reflecting equity compensation rather than a market trade.

How many AMETEK shares did Dean Seavers acquire and at what value?

Dean Seavers acquired 950 shares of AMETEK common stock in this transaction. The reported value per share is $212.77, and the shares are designated as restricted stock issued pursuant to the company’s 2020 Omnibus Incentive Compensation Plan.

What are Dean Seavers’ AMETEK share holdings after this Form 4 grant?

After this equity grant, Dean Seavers directly holds 5,600 shares of AMETEK common stock. This total reflects his position following the award of 950 restricted shares reported in the filing, all classified as directly owned non-derivative common stock.

Under which plan was the AMETEK restricted stock granted to Dean Seavers?

The restricted stock granted to Dean Seavers was issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. The footnote specifies that the 950-share award constitutes restricted stock granted pursuant to this omnibus incentive compensation program.

What transaction code is used for Dean Seavers’ AMETEK stock grant on Form 4?

The transaction uses code “A,” which indicates a grant, award, or other acquisition. In this case, the Form 4 describes the 950 AMETEK common shares as restricted stock issued under the company’s 2020 Omnibus Incentive Compensation Plan, rather than a purchase or sale.